Peroxisome Proliferator-Activated Receptor-γ Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer

Peroxisome proliferator-activated receptor-γ (PPAR-γ) has currently been considered as molecular target for the treatment of human metabolic disorders. Experimental data from in vitro cultures, animal models, and clinical trials have shown that PPAR-γ ligand activation regulates differentiation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Giaginis, Costas, Tsantili-Kakoulidou, Anna, Theocharis, Stamatios
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2008
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2366048/
https://www.ncbi.nlm.nih.gov/pubmed/18464916
http://dx.doi.org/10.1155/2008/431763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2366048/
https://www.ncbi.nlm.nih.gov/pubmed/18464916
http://dx.doi.org/10.1155/2008/431763

Ejemplares similares